Billlies First FullLength Album Marks a Commercial Milestone in KPops Evolving Landscape Gold and Silver Decline on Comex as Precious Metals Slide Lower Is Apollomics APLM Still a Buy After 1029 Rally 20260515 C3is CISS Q3 2025 Earnings EPS 058 In Line with Estimates Charter Communications Acquires Liberty Broadband in Improved Buyout Deal Dell Shares Surge on 97 Billion Pentagon Deal Q1 Earnings Expectations in Focus AnheuserBusch InBev Shares Slip After Sales Miss Estimates Huawei Unveils New Chip Design Approach Amid US Restrictions Intensifying Rivalry with Nvidia and Apple Bloom Energy Shares Maintain Upward Trajectory Key Drivers Behind the Move X formerly Twitter Fined A650000 by Australia for Child Protection Compliance Failures SPOK Q1 2026 Earnings EPS Misses Estimates Stock Declines SCM Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance LFCR Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction PHAR Q1 2026 Earnings EPS Misses Expectations by Wide Margin Stock Declines TOST Q1 2026 Earnings Profitability Surprise Drives Modest Stock Uptick EHTH Q1 2026 Earnings EPS Misses Estimates by 3466 Shares Fall 37 Brighthouse Financial Preferred Series A BHFAP Holds Steady Near 1542 Yield Support in Focus PennyMac Mortgage Investment Trust 900 Senior Notes PMTW Hold Steady Near Par Technical and Fundamental Outlook Safe Bulkers Inc SB Surges 320 as Dry Bulk Shipping Sentiment Improves DMC Global BOOM Hovers Near Support Amid Minimal Price Movement Deere Company Rebounds Navigating Agricultural Cycles and Technical Levels Turtle Beach TBCH Surges Over 11 as Gaming Peripheral Demand Shows Promise Corporate Confidence in Prediction Markets Grows Despite Regulatory Uncertainty TTI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Dare Bioscience DARE Edges Higher Amid Steady Support Levels Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels Launch One Acquisition Corp LPAA Holds Steady Near Resistance Amid Quiet Trading AXIA Energia AXIA Retreats from Resistance Support Levels Under Scrutiny MIRA Pharmaceuticals Edges Higher Consolidating Near Key Resistance at 104 Viatris VTRS Under Pressure Support Levels Tested After 15 Decline Sera Prognostics Surges 15 Key Resistance in Sight for SERA AbCellera Biologics ABCL Edges Higher as Biotech Sentiment Stabilizes